🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SUMMARY Rationale: Diagnostic laparoscopy (DL) and response assessment aft...
Status
Completed
Location
Erasmus MC
Start Date
2019-01-15
Trial ID
NCT05013775
Treatments Being Tested
Endometriosis (EM) is a chronic gynecological disorder characterized by dis...
Status
Completed
Location
Benha University
Start Date
2023-04-15
Trial ID
NCT07586488
Occult peritoneal metastases (OPM) in patients with pancreatic ductal adeno...
Status
Completed
Location
Shi Siya
Start Date
2021-01-01
Trial ID
NCT06336694
Treatments Being Tested
The COLOPEC II multicentre randomized trial will investigate the role of se...
Status
Active Not Recruiting
Location
Flevoziekenhuis
Start Date
2018-03-01
Trial ID
NCT03413254
Treatments Being Tested
This \[Study Type: Clinical Trial\] aims to \[Primary Objective: evaluate t...
Status
Recruiting
Location
The Southwest hospital of AMU
Start Date
2025-02-01
Trial ID
NCT06791538
Treatments Being Tested
Participants were diagnosed with esophageal cancer needing chemo- or radioc...
Status
Active Not Recruiting
Location
Stadtspital Zürich
Start Date
2024-11-30
Trial ID
NCT06712706
Treatments Being Tested
The number of cases of oesophagogastric cancer is increasing every year. Cu...
Status
Not Yet Recruiting
Location
Royal Surrey County Hospital
Start Date
2023-10
Trial ID
NCT06057220
Treatments Being Tested
Locally advanced Gall bladders cancers not amenable for curative resection ...
Status
Active Not Recruiting
Location
Tata Memorial Centre
Start Date
2016-09-06
Trial ID
NCT02867865
Treatments Being Tested
This study aims to determine the oncological effectiveness of adjuvant HIPE...
Status
Completed
Location
Academic Medical Center
Start Date
2015-03
Trial ID
NCT02231086
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2007-03
Trial ID
NCT00602602